youklip
FDA Approves Alzheimer's Drug Despite Serious Safety Risks
The FDA approved a drug for Alzheimer's that reduces amyloid plaque but fails to improve clinical outcomes. It carries a 33% risk of severe brain side effects, including swelling and bleeding.
AI-generated summary — may contain errors. How it works
Get clips like this delivered to your feed — follow topics and channels you care about.
Join YouKlip — Free